Leprosy Diagnostic Landscape

Conventional PCR (RLEP and Other Targets)

End-point amplification of M. leprae DNA, most often the multicopy RLEP repetitive element, with agarose gel or nested detection. It is widely reported and has low reagent costs, but is performed in an open-tube format with a risk of amplicon carry-over and gives no quantitative output. Performance values refer to RLEP-based assays.

Technology
Molecular (NAAT) · End-point PCR
What it measures
M. leprae DNA (RLEP and other targets)
Developer
Multiple laboratories
Specimen
Slit-skin smear
Development status
LDT with clinical validation
Regulatory status
None / RUO
Intended use
Confirmation of infection in bacilli-rich specimens
Main limitation
Open-tube format with a risk of amplicon carry-over, and no quantitative result.
Linked publications
312
TPP-1, confirming leprosy
22.0 of 100, low alignment
TPP-2, infection in contacts
14.5 of 100, low alignment
Open this test in the landscape

All 37 tests · Home